-
Product Insights
Taka Kyocera Solar PV Park
Taka Kyocera Solar PV Park is a solar PV project located in Hyogo, Japan. The project is owned by Kyocera Corp; Mitsubishi Research Institute Inc; Tokyo Century Corp; Yonden Engineering Corporation and was developed by Kyocera Corp; Tokyo Century Corp; Yonden Engineering Corporation. The project came online in 2016. Empower your strategies with our Taka Kyocera Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report...
-
Company Insights
Innovation and Patenting activity of Mitsubishi Research Institute Inc Q1 2024
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Mitsubishi Research Institute Inc Q1 2024". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Sector Analysis
Missiles and Missile Defense Systems Market Size and Trend Analysis by Segments, Programs, Competitive Landscape and Forecast to 2033
Missile Defense Systems Market Overview The global missiles and missile defense systems (MMDS) market is valued at $45.2 billion in 2023 and will grow at a compound annual growth rate (CAGR) of more than 4% during 2023-2033. The MMDS market will be driven by the rise in air defense modernization and advanced precision strike missile procurement programs by key defense spending countries, such as the US, Russia, China, India, Poland, and the UK, among others. The increased focus on the...
-
Sector Analysis
Missiles and Missile Defense Systems Market Analysis and Forecast to 2033 (Report Bundle)
The Global Missiles and Missile Defense Systems Market 2023–33 dataset provides the market size forecast and the estimated Compound Annual Growth Rate (CAGR) for the next ten years. The report covers industry analysis, including the key market drivers, trends, emerging technologies, and major challenges faced by industry participants. It also offers insights regarding key factors and government programs that are expected to influence the demand for the missiles and missile defense systems market over the forecast period. The quantitative report...
-
Product Insights
Amyotrophic Lateral Sclerosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Amyotrophic Lateral Sclerosis Clinical Trials Market Report Overview In total there were 694 clinical trials conducted on Amyotrophic Lateral Sclerosis, as of April 2023.The Amyotrophic Lateral Sclerosis clinical trial market research report provides an overview of the Amyotrophic Lateral Sclerosis clinical trials scenario. The report provides top-line data relating to the clinical trials on Amyotrophic Lateral Sclerosis. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage...
-
Company Profile
Mitsubishi Research Institute Inc – Company Profile
Mitsubishi Research Institute Inc (MRI) is a provider of research, consulting and information technology (IT) services. The company’s IT services include data processing services, operation and maintenance, information processing, outsourcing services, software development, and sales of system equipment. It serves public offices and government, private sector companies and financial institutions. The company also provides research and analysis, public policymaking and planning, consulting, and business support services. It serves social and public sector which includes national land development, transportation and traffic,...
Add to Basket -
Product Insights
Age Related Macular Degeneration Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Age Related Macular Degeneration Pipeline Drugs Market Overview Age related macular degeneration is the most common reason for vision loss in people aged above 50. It results in the depreciation of the macula which may lead to distorted or blurry central vision. The predisposing factors involved are age, smoking, sunlight, heredity, etc. Symptoms include the development of blind spots and hazy vision. The condition may be treated by photodynamic therapy, radiation therapy, and medication such as anti-angiogenic drugs. The Age...
-
Product Insights
Colorectal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Colorectal Cancer Pipeline Products Market Report Overview Colorectal cancer starts in the colon or the rectum. It begins as a growth called a polyp on the inner lining of the colon or rectum. Symptoms include abdominal pain and tenderness in the lower abdomen, blood in the stool, diarrhea, constipation, change in bowel habits, narrow stools, and weight loss with no known reasons. Risk factors for colorectal cancer include smoking, heavy alcohol use, inflammatory bowel disease (IBD), and family history. Treatment...
-
Product Insights
Poliomyelitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Poliomyelitis Drugs in Development Market Report Overview Polio is a highly infectious disease caused by a virus. It invades the nervous system and causes total paralysis in hours. Symptoms include fever, fatigue, headache, vomiting, stiffness in the neck and pain in the limbs. Preventive measures such as the use of vaccines are effective for polio. The Poliomyelitis drugs in development market research report provides comprehensive information on the Poliomyelitis targeted therapeutics, complete with analysis by indications, stage of development, mechanism...
-
Product Insights
Multiple Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Multiple Sclerosis Pipeline Drugs Development Market Report Overview Multiple sclerosis (MS) is a potentially debilitating disease in which the body's immune system eats away at the protective sheath (myelin) that covers nerves. Damage to myelin causes interference in the communication between the brain, spinal cord, and other areas of the body. Symptoms include numbness or weakness in one or more limbs, double vision or blurring of vision, tingling or pain in parts of the body, fatigue, and slurred speech. The...